Health-care policy in the US poses a challenge for investors, whereas there are areas of opportunity in the sector in Europe, according to
“You have very idiosyncratic things — executive orders that could create substantive change in Big Pharma,” Maldonado said in an interview with Bloomberg Television at the SuperReturn private capital conference in Berlin. “That does make dealmaking incredibly hard.”
Elsewhere such as Europe, “dealmaking and pockets of
Advent’s John Maldonado discusses private equity deals and says Europe is set to benefit as investment rotates away from the US. Advent has been busy in the region, with several deals signed or close to being finalized in recent weeks, Maldonado says. Source: Bloomberg
More broadly, the rotation in dealmaking ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.